{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:21:08Z","timestamp":1795137668147,"version":"4.10.3"},"reference-count":40,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,8,2]],"date-time":"2010-08-02T00:00:00Z","timestamp":1280707200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:p>Osteoporosis represents a prominent cause of morbidity in patients with thalassemia. The delay in sexual maturation, the presence of diabetes and hypothyroidism, the parathyroid gland dysfunction, the progressive marrow expansion, the iron toxicity on osteoblasts, the iron chelators, and the deficiency of growth hormone or insulin growth factors have been identified as major causes of osteoporosis in thalassemia. Adequate hormonal replacement, effective iron chelation, improvement of hemoglobin levels, calcium and vitamin D administration, physical activity, and smoking cessation are the main to\u2010date measures for the management of the disease. During the last decade, novel pathogenetic data suggest that the reduced osteoblastic activity, which is believed to be the basic mechanism of bone loss in thalassemia, is accompanied by a comparable or even greater increase in bone resorption. Therefore, the role of bisphosphonates, potent inhibitors of osteoclast activation, arises as a major factor in the management of osteoporosis in thalassemia patients.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2010.05542.x","type":"journal-article","created":{"date-parts":[[2010,8,2]],"date-time":"2010-08-02T22:38:48Z","timestamp":1280788728000},"page":"237-243","source":"Crossref","is-referenced-by-count":47,"title":["Treatment options for thalassemia patients with osteoporosis"],"prefix":"10.1111","volume":"1202","author":[{"given":"Evangelos","family":"Terpos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersi","family":"Voskaridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,8,2]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05143.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb10526.x"},{"issue":"1","key":"e_1_2_6_4_2","first-page":"86","article-title":"Pathogenesis and management of osteoporosis in thalassemia","volume":"6","author":"Voskaridou E.","year":"2008","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00310264"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907083410207"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980170079"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-002-1044-3"},{"key":"e_1_2_6_9_2","first-page":"1","article-title":"Assessment of fracture risks and its application to screening for post\u2010menopausal osteoporosis. Report of a WHO Study Group","volume":"843","author":"World Health Organization","year":"1994","journal-title":"World Health Organ. Tech. Rep. Ser."},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1385\/JCD:5:3S:S19"},{"issue":"3","key":"e_1_2_6_11_2","first-page":"795","article-title":"Genetic and acquired predisposing factors and treatment of osteoporosis in thalassaemia major","volume":"11","author":"Wonke B.","year":"1998","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2001.16.2.379"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200007)43:7<1456::AID-ANR7>3.0.CO;2-M"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2000.02382.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2000.13.2.179"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1998.13.5.763"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000066483"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02006.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(98)90237-2"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.040113"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021548"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01955263"},{"key":"e_1_2_6_23_2","first-page":"345","article-title":"Transferrin receptor\u20102 polymorphisms and iron overload in transfusion independent \u03b2\u2010thalassemia intermedia","volume":"88","author":"Ma E.S.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005131-198802000-00007"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02549.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04657.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02392.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2004.00395.x"},{"key":"e_1_2_6_29_2","first-page":"1193","article-title":"Zoledronic acid for the treatment of osteoporosis in patients with beta\u2010thalassemia: results from a single\u2010center, randomized, placebo\u2010controlled trial","volume":"91","author":"Voskaridou E.","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2007.02.020"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.9.1682"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2008.000893"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90571-W"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb01876.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1159\/000204084"},{"issue":"3","key":"e_1_2_6_36_2","first-page":"779","article-title":"Bone pain in thalassaemia: assessment of DEXA and MRI findings","volume":"11","author":"Angastiniotis M.","year":"1998","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"2","key":"e_1_2_6_37_2","first-page":"303","article-title":"The bone density of thalassemic patients of Boo Ali Sina hospital, Sari, Iran in 2002; does hydroxyurea help?","volume":"2","author":"Kosaryan M.","year":"2004","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980200087"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-003-0435-5"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12849"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1159\/000114869"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2010.05542.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2010.05542.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:28:33Z","timestamp":1695601713000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2010.05542.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1111\/j.1749-6632.2010.05542.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05542.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}